CEO, CSO
SYNAXYS
The biotechnology company specializes in electrophysiological assays combined with microscopy, genomic, and proteomic data to evaluate new treatments for nervous system diseases. This approach provides medical researchers with preclinical data that can be directly utilized in laboratory settings, facilitating the development of effective therapies.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$450KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The biotechnology company specializes in electrophysiological assays combined with microscopy, genomic, and proteomic data to evaluate new treatments for nervous system diseases. This approach provides medical researchers with preclinical data that can be directly utilized in laboratory settings, facilitating the development of effective therapies.